Casa Minerals Inc New (PK) (CASXF) News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow

TORONTO, July 18, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the...

Form EFFECT - Notice of Effectiveness

Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases

TORONTO, July 11, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the...

Form F-X - Appointment of Agent for Service of Process and Undertaking

Form F-10 - Registration Statement for Securities of certain Canadian Issuers.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Profound Medical Annual General Meeting of Shareholders Voting Results

TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the...

PROFOUND MEDICAL ANNUAL GENERAL MEETING OF SHAREHOLDERS VOTING RESULTS

PROFOUND MEDICAL ANNUAL GENERAL MEETING OF SHAREHOLDERS VOTING RESULTS Canada NewsWire TORONTO, May 15, 2024 TORONTO, May 15, 2024 /CNW/...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan

– Prostate segmentation using a deep learning convolutional neural network – – Model uses 24,611,072...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance

TORONTO, May 09, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]